In this preliminary study, we discuss 9 cases of Candidosis diagnosed during a 6 month period in 32 AIDS patients hospitalized in three health Centers in Yaoundé. Most of the patients presented with buccal candidosis and/or dysphagia. Of the 18 strains grown, 17 (94%) are Candida albicans.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
meningitis in a patient with newly diagnosed acquired immunodeficiency syndrome from Sikkim, India.
Curr Med Mycol
May 2024
Department of Microbiology, Sikkim Manipal Institute of Medical Science, Gangtok, India.
Background And Purpose: infections in India have shifted, with an increase in the incidence rate of invasive candidiasis, particularly due to non- species. The central nervous system infections by are sparsely reported and more understanding and research is needed regarding these infections.
Case Report: This study reported an unusual case of meningitis in a middle-aged female with pulmonary tuberculosis and newly diagnosed acquired immunodeficiency syndrome with a low cluster of differentiation 4 count (12 cells/mm).
Exploring the Biology, Virulence, and General Aspects of .
Infect Drug Resist
December 2024
Departamento de Biología, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Gto, Mexico.
Fungal infections have become a growing public health concern, aggravated by the emergence of new pathogenic species and increasing resistance to antifungal drugs. The most common candidiasis is caused by ; however, has become an emerging opportunistic pathogen, and although less prevalent, it can cause superficial and systemic infections, especially in immunocompromised individuals. This yeast can colonize the oral cavity, skin, and other tissues, and has been associated with oral infections in patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), making it difficult to treat.
View Article and Find Full Text PDFCompeting risks multi-state model for time-to-event data analysis of HIV/AIDS: a retrospective cohort national datasets, Ethiopia.
BMC Infect Dis
December 2024
Department of Epidemiology and Biostatistics, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Introduction: Tuberculosis (TB) remains the most common opportunistic infection and leading cause of death among individuals living with HIV/AIDS in Ethiopia. Its significant impact on morbidity and mortality underscores the crucial link between these two diseases. While the advent of antiretroviral therapy (ART) has led to a dramatic decline in mortality rates among HIV/AIDS patients, TB continues to pose a substantial threat.
View Article and Find Full Text PDFExtracellular hydrolytic enzyme activities and biofilm formation in Candida species isolated from people living with human immunodeficiency virus with oropharyngeal candidiasis at HIV/AIDS clinics in Uganda.
Microb Pathog
February 2025
Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, P.O. Box 7072, Makerere University, Kampala, Uganda. Electronic address:
Article Synopsis
- Commensal oral Candida species can turn pathogenic in people with weakened immune systems, leading to oropharyngeal candidiasis (OPC) due to various factors.
- The study assessed several enzymatic activities (phospholipase, proteinase, hemolysin, esterase, and coagulase) and biofilm formation in 35 Candida isolates from people living with HIV experiencing OPC.
- Results revealed that most isolates exhibited strong phospholipase and proteinase activities, with significant biofilm formation, while other enzymatic activities were less prevalent.
Impact of Biologic and Disease-Modifying Anti-rheumatic Drug (DMARD) Therapies on Oral Health in Rheumatologic Patients: A Case-Control Study.
Cureus
November 2024
Rheumatology, Ministry of Health, Erbil, IRQ.
Background: Disease-modifying anti-rheumatoid drugs (DMARDs) and biological therapies are known to alter immune function, which may increase the risk of oral infections and mucosal changes. Immunosuppression induced by these medications can make patients more susceptible to conditions like oral candidiasis. Furthermore, there is limited research exploring the long-term oral health outcomes associated with these treatments, particularly in rheumatologic patients who are already at a higher risk of systemic inflammation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!